Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients;Atypische neuroleptika in der behandlung von aggressivität und feindseligkeit bei schizophrenen patienten

Fortschritte der Neurologie Psychiatrie

Volumn 70, Issue 3, 2002, Pages 139-144

  Briken, P ^a   Nika, E ^a   Krausz, M ^a   Naber, D ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTINDOLE; ZIPRASIDONE; ZOTEPINE;

AGGRESSION; ARTICLE; DRUG CHOICE; DRUG EFFICACY; HOSTILITY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; PATIENT COMPLIANCE; PEER REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; HOSTILITY; HUMANS; PIRENZEPINE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036121638     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20501     Document Type: Article

References (42)

1. Violence and psychiatric epidemiologic catchment area surveys
2. Schizophrenia: Violence and comorbidity
3. The epidemiology of crime, violence and schizophrenia
4. The cost of staff injuries from inpatient violence
5. Psychiatrische notfälle im notarztdienst einer deutschen großstadt
6. Cost of relapse in schizophrenia
7. The effects of clozapine on aggression and substance abuse in schizophrenic patients
8. Correlates of violence in psychotic patients
9. The role of typical and atypical antipsychotic medications in the management of agitation and aggression
10. Primate models to understand human aggression
11. The neurobiology of impulsive aggression
12. Symptomorientierte pharmakotherapie bei borderline-persönlichkeitsstörungen
13. Therapie mit dem LHRH-agonisten leuprorelinacetat bei paraphilien und sexuell aggressiven impulshandlungen
14. Atypical antipsychotics in the treatment of the presistently aggressive psychotic patient: Methodologic concerns
15. Profiles of aggression among psychiatric patients. 1. Nature and prevalence
16. Symptoms and personality characteristics of patients in a maximum security psychiatric unit
17. Clinical review of clozapine treatment in a state hospital
18. Patients response to clozapine in a forensic psychiatric hospital
19. Effects of clozapine on use of seclusion and restraint at a state hospital
20. Restraint, seclusion and clozapine
21. The impact of clozapine on 25 forensic patients
22. Clozapine effects on hostility and aggression in schizophrenia
23. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital
24. Violence and schizophrenia: Clozapine as a specific antiaggressive agent
25. 18-Month outcome of clozapine treatment for 100 patients in a state hospital
26. Effect of clozapine on physical and verbal aggression
27. Novel antipsychotic agents and their implications for forensic psychiatry
28. Effect of risperidone on hostility in schizophrenia
29. Impact of risperidone on seclusion and restraint at a state psychiatric hospital
30. Aggression and schizophrenia: Efficacy of risperidone
31. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility
32. The influence of pharmacotherapy on self-directed and externally-directed aggression in schizophrenia
33. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia
34. The efficacy and tolerability of intramuscular (i. m.) ziprasidone versus i. m. haloperidol in patients with acute, non-organic psychosis
35. A comparison of rapid acting, intramuscular (i. m.) ziprasidone 2 mg and 20 mg in patients with psychosis and acute agitation
36. The atypical antipsychotic sertindole: A case series [CME]
37. Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients
38. Gewichtszunahme bei gabe von atypischen neuroleptika - Eine unterschätzte nebenwirkung?
39. Violence and severe mental illness: The effects of substance abuse and nonadherence to medication